Exogenous TNF administration is a well-known experimental model to induce lethal SIRS as it triggers an acute inflammatory response marked by excessive release of several toxic mediators such as interleukins (e.g. IL-1, IL-6, IL-17), type I interferons and matrix metalloproteinases (3, 9–13). The gene discussed is TNF; the disease is systemic inflammatory response syndrome.